Cargando...
Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection
BACKGROUND AND AIMS: This study aimed to clarify the clinical picture of hepatitis C virus (HCV) carriers with normal alanine aminotransferase (CNALT) and those with ALT elevation (non‐CNALT) under direct‐acting antivirals (DAAs). METHODS: We enrolled 1002 patients with HCV (427 men, median age: 69 ...
Gardado en:
| Publicado en: | JGH Open |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley Publishing Asia Pty Ltd
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7411565/ https://ncbi.nlm.nih.gov/pubmed/32782941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12296 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|